Clinical Trials Browser

Phase 2 × Not yet recruiting × Endometrial Neoplasms × Clear all

NCT07446049 2026-03-03

A Single-arm, Open-label, Multicenter, Phase Ib/II Clinical Trial of CVL237 Tablets in Combination With Serplulimab Injection for the Treatment of Advanced Solid Tumors With PTEN Loss or Low Expression

Phase 2 Not yet recruiting

BreastGastrointestinalGynecologicThoracic

Breast Neoplasms, Uterine Cervical Neoplasms, Lung Neoplasms, Ovarian Neoplasms, Stomach Neoplasms, Endometrial Neoplasms

NCT07377734 2026-01-30

A Multicenter, Randomized, Open-Label, Controlled Clinical Trial of Intrauterine Injection of Recombinant Humanized Type III Collage in the Fertility-Sparing Treatment of Endometrial Cancer or Atypical Hyperplasia

Phase 2 Not yet recruiting

Endometrial Hyperplasia, Endometrial Neoplasms

NCT07369986 2026-01-27

IMMUNE-SAVE

Phase 2 Not yet recruiting

Turcot syndrome, Endometrial Neoplasms

NCT07139977 2026-01-20

EV-4-EC

Phase 2 Not yet recruiting

Endometrial Neoplasms

NCT07078838 2026-01-16

Tirzepatide in Women With Obesity and Endometrial Intra-epithelial Neoplasia or Grade 1 Endometrial Cancer

Phase 2 Not yet recruiting

GynecologicOther

Endometrial Hyperplasia, Hyperplasia, Obesity, Endometrial Neoplasms

NCT07170982 2025-09-12

Fruquintinib Combined With Standard Chemotherapy Versus Standard Chemotherapy as First-line Treatment for Advanced pMMR Endometrial Cancer

Phase 2 Not yet recruiting

Endometrial Neoplasms

NCT07115927 2025-08-19

RODEO

Phase 2 Not yet recruiting

Endometrial Neoplasms

NCT06942377 2025-07-08

Calcium Channel Blocker Amlodipine for Endometrial Cancer Therapy

Phase 2 Not yet recruiting

Endometrial Neoplasms

NCT06073184 2025-06-10

WE-FiERCE

Phase 2 Not yet recruiting

Endometrial Neoplasms

NCT06771154 2025-01-13

A-CAPE

Phase 2 Not yet recruiting

Endometrial Neoplasms

NCT06751277 2024-12-27

QL1706 Combined with Chemotherapy in the Treatment of Recurrent or Metastatic Endometrial Cancer

Phase 2 Not yet recruiting

Recurrence, Endometrial Neoplasms

NCT06548763 2024-08-12

Oral Topotecan With Toripalimab for Patients With Endometrial Cancer

Phase 2 Not yet recruiting

Endometrial Neoplasms

NCT06297811 2024-03-07

Myeloprotection With Trilaciclib in Pan-cancer Population

Phase 2 Not yet recruiting

BreastGynecologicHead & NeckThoracic

Squamous Cell Carcinoma of Head and Neck, Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Uterine Cervical Neoplasms, Endometrial Neoplasms

NCT06066216 2024-01-23

Cadonilimab (AK104) Plus Chemotherapy in Patients With Recurrent or Advanced Endometrial Cancer

Phase 2 Not yet recruiting

Endometrial Neoplasms

NCT05805358 2023-08-30

DNPSPIO

Phase 2 Not yet recruiting

Uterine Cervical Neoplasms, Ovarian Neoplasms, Endometrial Neoplasms